• Advanced renal cell carcinoma
• Advanced hepatocellular carcinoma
• Differentiated  thyroid carcinoma

Adtrinib Tablet works by inhibiting multiple protein kinases involved in tumour cell proliferation and angiogenesis (the formation of new blood vessels that supply tumours). Specifically, it targets receptors for vascular endothelial growth factor (VEGF), platelet-derived growth factor (PDGF), and Raf kinases, which play key roles in cancer development and progression.  This stops the growth and spread of the tumour cells to other organs, as well as the formation of blood vessels in the tumour cells.

Inform your healthcare provider about all the medicines you take, including prescription, over-the-counter, nutritional or vitamin supplements, and herbal products. Certain medications may interact with Adtrinib Tablet and reduce effectiveness by causing undesirable side effects.

• Store Adtrinib Tablet Tablet in the original package at room temperature (20°C to 25°C).
• Keep it out of reach from children.

A healthcare professional in a hospital setting will prescribe the medicine to you. It is not recommended to take this medication with meals that are high in fat since this may reduce Adtrinib Tablet's effectiveness. If you plan to eat one, take the pills at least one hour before or two hours after.

Your healthcare professional will decide the dose based on your conditions. Avoid crushing, opening, or dissolving the tablet; swallow it whole with a glass of water. Take the Adtrinib tablet at the same time every day.

Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them.

Common:

• Nausea
• Vomiting
• Fatigue
• Diarrhoea
• Alopecia
• Hand foot skin reaction
• Gut wall bleeding

Serious:

• gastrointestinal perforation
• abnormal heart rhythm (QT prolongation)
• inflammation of the liver
• breathing or swallowing difficulties
• Stevens Johnsons Syndrome and toxic epidermal necrolysis
• Decreased blood flow to the heart
• Increased risk of bleeding (blood in urine, stool, vomit, cough, etc)

Follow all instructions and dosing recommendations provided by your healthcare provider. Do not take more or less of the medication than prescribed. Report any new or worsening symptoms to your healthcare provider immediately, especially if they relate to your lungs, eyes, skin, liver, kidneys, heart, or bleeding. When undergoing this therapy, stay out of direct sunlight and wear sunscreen with an SPF of at least 50 before going outside. Adtrinib Tablet should not be stopped without first talking to your doctor. Even if you feel better or see a change in your symptoms, you should still talk to your doctor before stopping Adtrinib Tablet. It is recommended to inform your doctor about other anticancer drugs you have been taking.  It's critical to maintain a sufficient fluid intake because dehydration can exacerbate symptoms such as diarrhea and other gastrointestinal disorders. Remember to attend all scheduled appointments and follow-up visits with your healthcare provider to ensure your treatment is effective and any side effects are managed appropriately.

1. Bayer (Pty) Ltd, [Revised on 22nd Apr 2016] [Accessed on  15th March 2024], https://www.bayer.com/sites/default/files/NEXAVAR_200_EN_PI.pdf

2. Bayer HealthCare Pharmaceuticals Inc., US Food & Drug Administration, [Revised on Dec 2018] [Accessed on 15th  March 2024]], https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021923s020lbl.pdf

3. Bayer AG, European Medicines Compendium (emc), [Revised on April 2023], [Accessed on  15th March 2024], https://www.medicines.org.uk/emc/files/pil.226.pdf

4. Zentiva Pharma UK Limited,  Medicines Compendium (emc), [Revised on April 2022], [Accessed on  15th March 2024] https://www.medicines.org.uk/emc/files/pil.13098.pdf

5. KD Tripathi, Anticancer Drugs, Essentials of Medical Pharmacology, 8th Edition, 2019, 915-936.